|
DE2615061A1
(de)
|
1976-04-05 |
1977-10-06 |
Wolfgang Dr Med Wagner |
Injektionsverfahren und -vorrichtungen
|
|
US4252159A
(en)
|
1979-04-02 |
1981-02-24 |
Maki Eugene B |
Dosage device
|
|
JPS60172925A
(ja)
|
1984-02-17 |
1985-09-06 |
Kao Corp |
胆石溶解剤
|
|
JPS6115809A
(ja)
|
1984-06-29 |
1986-01-23 |
Lion Corp |
細胞賦活剤
|
|
DE3501534A1
(de)
|
1984-09-22 |
1986-05-15 |
Walter Ing.(grad.) 7758 Meersburg Holzer |
Verfahren und vorrichtung zum dosieren von insulin oder aehnlichen langzeitmedikamenten
|
|
JPS6212716A
(ja)
|
1985-07-11 |
1987-01-21 |
Nippon Oil & Fats Co Ltd |
制がん剤
|
|
JPH0672142B2
(ja)
|
1986-10-15 |
1994-09-14 |
コニカ株式会社 |
４−アミノ−１，２，４−トリアゾリン−５−チオン系化合物の製造方法
|
|
EP0317705B1
(de)
|
1987-11-25 |
1992-09-30 |
Siemens Aktiengesellschaft |
Dosiergerät zum gesteuerten Injizieren von Flüssigkeiten aus einem Vorratsbehälter in einen Organismus
|
|
EP0569618B1
(de)
|
1992-05-12 |
1997-01-02 |
Siemens-Elema AB |
Dosiergerät zur gesteuerten Abgabe einer Flüssigkeit
|
|
JP3558351B2
(ja)
|
1992-12-07 |
2004-08-25 |
邦郎 辻 |
免疫抑制剤
|
|
US5449688A
(en)
|
1993-03-30 |
1995-09-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of treating chronic inflammatory diseases
|
|
US5465728A
(en)
|
1994-01-11 |
1995-11-14 |
Phillips; Michael |
Breath collection
|
|
US5741816A
(en)
|
1994-06-20 |
1998-04-21 |
Tanabe Seiyaku Co., Ltd. |
Hair-growth agent
|
|
AUPN137895A0
(en)
|
1995-02-27 |
1995-03-16 |
Clover Corporation Pty Ltd |
Composition and method
|
|
AUPN250795A0
(en)
|
1995-04-20 |
1995-05-18 |
Cultor Ltd. |
Stress regulator
|
|
AU744189B2
(en)
|
1997-06-23 |
2002-02-14 |
Neuro Therapeutics Limited |
Neurologically-active compounds
|
|
RU2141483C1
(ru)
|
1997-07-04 |
1999-11-20 |
Небольсин Владимир Евгеньевич |
Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
|
|
IL121268A0
(en)
|
1997-07-09 |
1998-01-04 |
Dpharm Ltd |
Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
|
|
BR9813264A
(pt)
|
1997-10-23 |
2000-12-26 |
Procter & Gamble |
ácidos graxos, sistemas tensoativos e produtos de consumo baseados nos mesmos
|
|
ES2198661T3
(es)
|
1998-01-21 |
2004-02-01 |
Fideline |
Composiciones que contienen feromonas para disminuir el estres, la ansiedad y la agresividad en los cerdos.
|
|
US6214875B1
(en)
|
1998-04-14 |
2001-04-10 |
Zhenhua Yang |
Anticancer effects of specific branched-chain fatty acids and related production process
|
|
WO1999058120A1
(en)
|
1998-05-08 |
1999-11-18 |
Rolf Berge |
USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
|
|
US6159485A
(en)
|
1999-01-08 |
2000-12-12 |
Yugenic Limited Partnership |
N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
|
|
US6544541B1
(en)
|
1999-06-02 |
2003-04-08 |
Cardiovascular Solutions, Inc. |
Devices and compounds for treating arterial restenosis
|
|
US7012053B1
(en)
|
1999-10-22 |
2006-03-14 |
The Procter & Gamble Company |
Fabric care composition and method comprising a fabric care polysaccharide and wrinkle control agent
|
|
US6835750B1
(en)
|
2000-05-01 |
2004-12-28 |
Accera, Inc. |
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
|
|
NO20006008L
(no)
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US6635015B2
(en)
|
2001-04-20 |
2003-10-21 |
The Procter & Gamble Company |
Body weight management system
|
|
US7402405B2
(en)
|
2001-06-05 |
2008-07-22 |
The Children's Hospital Of Philadelphia |
Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
|
|
DK1417211T3
(da)
|
2001-07-27 |
2007-10-08 |
Neptune Technologies & Bioress |
Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse
|
|
FR2828487B1
(fr)
|
2001-08-09 |
2005-05-27 |
Genfit S A |
Nouveaux composes derives d'acides gras, preparation et utilisations
|
|
JP2003160486A
(ja)
|
2001-09-17 |
2003-06-03 |
Lion Corp |
経口養育毛剤及び該養育毛剤を含有する飲食品
|
|
US20030203004A1
(en)
|
2002-04-24 |
2003-10-30 |
Kelm Gary Robert |
Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
|
|
US20030203042A1
(en)
|
2002-04-24 |
2003-10-30 |
Cook Lisa Ann |
Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
|
|
US20060275294A1
(en)
|
2002-08-22 |
2006-12-07 |
Omoigui Osemwota S |
Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer
|
|
JP4286513B2
(ja)
|
2002-09-26 |
2009-07-01 |
株式会社ファンケル |
抗老化用組成物
|
|
SE0203886D0
(sv)
|
2002-12-27 |
2002-12-27 |
Ltp Lipid Technologies Provide |
Glycerolesterprodukt och dess användning
|
|
ITMI20030210A1
(it)
|
2003-02-07 |
2004-08-08 |
Res & Innovation Soc Coop A R L |
Composti endocannabinoido-simili e loro impiego
|
|
SE0303513D0
(sv)
|
2003-12-19 |
2003-12-19 |
Pronova Biocare As |
Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
|
|
WO2005099483A1
(en)
|
2004-04-16 |
2005-10-27 |
Indevex Ab |
Ingestible composition
|
|
WO2005113036A1
(en)
|
2004-05-13 |
2005-12-01 |
The Regents Of The University Of California |
Method and apparatus for glucose control and insulin dosing for diabetics
|
|
WO2005120484A1
(ja)
|
2004-06-09 |
2005-12-22 |
Kurume University |
グレリンの生理学的機能のレギュレーター
|
|
EP1773317A4
(en)
|
2004-07-02 |
2012-10-03 |
Baylor Res Inst |
METHOD OF TREATING OVERLOADING DISEASE DUE TO ACCUMULATION OF GLYCOGENES OR POLYSACCHARIDES
|
|
CA2483675A1
(en)
|
2004-10-01 |
2006-04-01 |
Jens Peschardt |
Food bar
|
|
CA2587444C
(en)
|
2004-11-12 |
2013-09-10 |
Ucl Business Plc |
Guanidine derivatives as inhibitors of ddah
|
|
JP2006169386A
(ja)
*
|
2004-12-16 |
2006-06-29 |
Showa Shell Sekiyu Kk |
潤滑グリース組成物及びそれを用いた軸受
|
|
WO2006117668A1
(en)
|
2005-05-04 |
2006-11-09 |
Pronova Biopharma Norge As |
Fatty acid analogues, i.e. dha derivatives for uses as a medicament
|
|
US20060269495A1
(en)
|
2005-05-25 |
2006-11-30 |
Popp Karl F |
Alpha hydroxy acid compositions
|
|
US8251904B2
(en)
|
2005-06-09 |
2012-08-28 |
Roche Diagnostics Operations, Inc. |
Device and method for insulin dosing
|
|
WO2007002365A2
(en)
|
2005-06-24 |
2007-01-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Modulation of amino acid metabolism in the hypothalamus
|
|
CN100579534C
(zh)
|
2005-09-30 |
2010-01-13 |
中国科学院上海药物研究所 |
S-腺苷同型半胱氨酸在制药中的应用
|
|
US20070203235A1
(en)
|
2006-02-28 |
2007-08-30 |
Rosales Francisco J |
Method for preventing or treating anemia
|
|
EP2123253B1
(en)
|
2007-03-16 |
2017-06-28 |
Shiseido Company, Ltd. |
Wrinkling-preventing and -alleviating agent
|
|
JP2008255022A
(ja)
|
2007-04-02 |
2008-10-23 |
Kureha Corp |
抗癌性物質
|
|
NZ555163A
(en)
|
2007-05-14 |
2010-05-28 |
Fonterra Co Operative Group |
Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
|
|
WO2009026153A1
(en)
|
2007-08-17 |
2009-02-26 |
Metabolon, Inc. |
Biomarkers for alzheimer's disease and methods using the same
|
|
DE102007055636A1
(de)
|
2007-11-21 |
2009-05-28 |
Robert Bosch Gmbh |
Medikamenten-Dosiervorrichtung zum Verabreichen eines flüssigen Medikaments
|
|
FR2931676B1
(fr)
|
2008-05-30 |
2011-01-14 |
Ceva Sante Animale |
Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
|
|
CA2727223C
(en)
|
2008-06-11 |
2014-10-07 |
Ricom Corporation |
Human .beta.3 adrenergic receptor ligand, and food or pharmaceutical product containing the same
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
CN102481276A
(zh)
|
2009-04-20 |
2012-05-30 |
埃尔舍利克斯治疗公司 |
基于化学感受受体配体的治疗法
|
|
BRPI1015120B8
(pt)
|
2009-05-08 |
2022-02-15 |
Basf As |
Composto lipídico alfa-substituídos, derivados de ácidos graxos beta-oxo poli-insaturados, composição farmacêutica e lipídica e métodos para produzir composto lipídico e ácido 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaeniloxi)butanóico
|
|
JP2010260833A
(ja)
|
2009-05-11 |
2010-11-18 |
Daicho Kikaku:Kk |
抗自己免疫疾患剤
|
|
US10052299B2
(en)
|
2009-10-30 |
2018-08-21 |
Retrotope, Inc. |
Alleviating oxidative stress disorders with PUFA derivatives
|
|
KR20120129898A
(ko)
|
2009-12-30 |
2012-11-28 |
베일러 리서치 인스티튜트 |
알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법
|
|
EP2574172A4
(en)
|
2010-05-21 |
2013-10-30 |
Cytogel Pharma Llc |
MATERIALS AND METHOD FOR TREATING INFLAMMATION
|
|
EA201370008A1
(ru)
|
2010-07-01 |
2013-06-28 |
Айсис Инновэйшн Лимитид |
Лечение когнитивных нарушений
|
|
US20120072236A1
(en)
|
2010-08-06 |
2012-03-22 |
Benjamin Atkin |
Insulin pen data recording and transmission device
|
|
CN102327368B
(zh)
|
2010-09-06 |
2013-07-24 |
成都地奥制药集团有限公司 |
三白草根茎总有效部位及其制备方法和用途
|
|
BR112013005806B1
(pt)
|
2010-09-10 |
2022-05-10 |
Epizyme, Inc |
Métodos para detectar se um indivíduo é um candidato para o tratamento com ou responsivo a um inibidor de ezh2 e usos terapêuticos do dito inibidor de ezh2
|
|
GB201020133D0
(en)
|
2010-11-26 |
2011-01-12 |
Royal Holloway & Bedford New College |
Therapeutic use of compounds
|
|
WO2012071589A2
(en)
|
2010-11-27 |
2012-05-31 |
Ross Philip G |
Method for producing fungus structures
|
|
WO2012108954A2
(en)
|
2011-02-09 |
2012-08-16 |
Becton, Dickinson And Company |
Nighttime basal dosing device
|
|
ITMI20111284A1
(it)
|
2011-07-11 |
2013-01-12 |
Giovanni Nusca |
Composizione farmaceutica.
|
|
US20140303228A1
(en)
|
2011-10-18 |
2014-10-09 |
Metabolon, Inc. |
Biomarkers for Amyotrophic Lateral Sclerosis and Methods Using the Same
|
|
JP6263124B2
(ja)
|
2012-10-17 |
2018-01-17 |
国立大学法人 岡山大学 |
化合物、その互変異性体、幾何異性体、乃至それらの塩、及びそれらの製造方法、抗菌剤、並びに感染症治療薬
|
|
KR102235264B1
(ko)
|
2013-01-14 |
2021-04-02 |
인퍼스트 헬스케어 리미티드 |
고용체 조성물들 및 심각한 통증에서의 이들의 용도
|
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
|
WO2014179341A1
(en)
|
2013-04-29 |
2014-11-06 |
Matinas Biopharma, Inc. |
Treatment with omega-3 fatty acid compositions
|
|
JP2015010067A
(ja)
|
2013-06-28 |
2015-01-19 |
奥野製薬工業株式会社 |
肝機能改善用製剤
|
|
WO2015110977A1
(en)
|
2014-01-22 |
2015-07-30 |
Rolexi Marketing (Pty) Ltd |
Fatty acid composition and medicinal use thereof
|
|
DK3116511T3
(da)
|
2014-03-14 |
2020-11-23 |
Alltech Inc |
Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
|
|
GB201405033D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Combination therapy
|
|
WO2015157514A1
(en)
|
2014-04-09 |
2015-10-15 |
The Johns Hopkins University |
Ribosomal protein s15 phosphorylation mediates lrrk2 neurodegeneration in parkinson's disease
|
|
JP7171190B2
(ja)
|
2014-11-11 |
2022-11-15 |
コーニンクレッカ フィリップス エヌ ヴェ |
線源－検出器装置
|
|
US9662306B2
(en)
|
2015-01-07 |
2017-05-30 |
The United States Of America, As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of metabolic syndrome
|
|
US9561206B2
(en)
|
2015-01-07 |
2017-02-07 |
The United States Of America, As Represented By The Secretary Of The Navy |
Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
|
|
US10022347B2
(en)
|
2015-01-07 |
2018-07-17 |
The United States Of America, As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of metabolic syndrome
|
|
GB201521085D0
(en)
|
2015-11-30 |
2016-01-13 |
Biozep As |
Use
|
|
KR101830244B1
(ko)
|
2016-01-20 |
2018-02-21 |
서울대학교 산학협력단 |
신규한 헤테로방향족 고리 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 s1p 수용체 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
JP2017200910A
(ja)
|
2016-04-28 |
2017-11-09 |
ライオン株式会社 |
血糖値上昇抑制剤
|
|
EP3448427A1
(en)
|
2016-04-29 |
2019-03-06 |
CureVac AG |
Rna encoding an antibody
|
|
KR20180036318A
(ko)
|
2016-09-30 |
2018-04-09 |
경북대학교 산학협력단 |
2-아미노-2-(1-도데실-1h-1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체를 유효성분으로 포함하는 퇴행성 신경질환 및 우울증 예방 또는 치료용 약학적 조성물
|
|
US10238618B2
(en)
|
2016-12-29 |
2019-03-26 |
The United States Of America As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of anemia
|
|
US10307388B2
(en)
|
2016-12-29 |
2019-06-04 |
The United States Of America As Represented By The Secretary Of The Navy |
Compositions and methods for diagnosis and treatment of inflammation
|
|
US20200241011A1
(en)
|
2017-02-24 |
2020-07-30 |
Mattias ARNOLD |
Compositions and methods related to sex- specific metabolic drivers in alzheimers disease
|
|
KR102701244B1
(ko)
|
2017-10-23 |
2024-09-02 |
에피트래커, 인코포레이티드 |
지방산 유사체 및 대사 증후군 관련 병태 치료에서의 그의 용도
|
|
KR102017324B1
(ko)
|
2018-04-30 |
2019-09-02 |
경북대학교 산학협력단 |
신규한 asm 활성 직접 억제 화합물 2-아미노-2-(1,2,3-트리아졸-4-일)프로판-1,3-디올 유도체 및 이의 용도
|
|
AU2019271067B2
(en)
|
2018-05-16 |
2023-08-03 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to aging
|
|
AU2019274431B2
(en)
|
2018-05-23 |
2025-03-13 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
|
|
KR102087634B1
(ko)
|
2018-10-11 |
2020-03-11 |
(주)바이텍 |
항비만용 조성물
|
|
CA3122246C
(en)
|
2018-12-05 |
2025-06-10 |
Celagenex Research (India) Pvt. Ltd. |
Synergistic compositions of bioactive agents to optimize cell health
|
|
EP3908374A4
(en)
|
2019-01-09 |
2022-12-28 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
EP3914242A4
(en)
|
2019-01-23 |
2023-02-01 |
Epitracker, Inc. |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF QUALITY OF AGING AND LONGEVITY DISORDERS
|
|
JP7404382B2
(ja)
|
2019-03-04 |
2023-12-25 |
エピトラッカー インコーポレイテッド |
脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
|
|
WO2022040340A1
(en)
|
2020-08-20 |
2022-02-24 |
Epitracker, Inc. |
Compositions and methods for treatment of obesity
|
|
WO2022098572A1
(en)
|
2020-11-03 |
2022-05-12 |
Epitracker, Inc. |
Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
|
|
EP4426130A1
(en)
|
2021-11-03 |
2024-09-11 |
Epitracker, Inc. |
Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity
|